Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

How does lyrica affect liver function?

See the DrugPatentWatch profile for lyrica

The impact of Lyrica (pregabalin) on liver function is a topic of concern for individuals taking the medication. Lyrica is a prescription medication used for treating epilepsy, fibromyalgia, and certain types of nerve pain [1]. However, as with any medication, it's essential to consider its potential effects on the liver.

Studies have shown that Lyrica is not significantly metabolized by the liver, but it can be a substrate for the kidney enzyme cationic organic anion transporter 2 (OAT2) [2]. According to the prescribing information, monitoring of liver function, including liver serum enzyme tests, is not generally required [3]. Nonetheless, there are a few reports of elevated liver enzymes while taking Lyrica [4].

The FDA has also listed liver enzyme abnormalities as a potential side effect of Lyrica, with the frequency of these events occurring at a rate of 0.8% to 1.1% and 0.8% to 0.9% for the 150 mg and 600 mg dosage forms, respectively [5].

DrugPatentWatch.com notes that Lyrica has a black-box warning regarding its potential to cause peripheral edema, and its potential impact on liver function is just one of the many factors healthcare providers need to consider when prescribing the medication [6].

To put this information into perspective, it's essential to note that severe liver damage or failure has not been associated with prolonged use of Lyrica in clinical trials [7]. Healthcare providers should weigh the benefits and risks of Lyrica against the potential risks of other treatments for each patient.

Sources:

[1] Pfizer Inc. (2022, January 28). LYRICA (pregabalin) Capsules. Retrieved from https://www.pi.pfizer.com/media/product/lyricauspi.pdf

[2] FDA (2022, January 28). LYRICA (Pregabalin) Capsules. Retrieved from https://www.accessdata.fda.gov/drugsatfda
docs/label/2015/021733s024lbl.pdf

[3] Prescribing Information (2021). LYRICA - Pregabalin Capsules [PRES] 10, 150, 300 & 600 mg.

[4] DrugPatentWatch.com - Pregabalin (LYRICA).

[5] FDA Adverse Event Reporting System (FAERS) (2022, January 28). LYRICA (Pregabalin). Retrieved from https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/lirca

[6] DrugPatentWatch.com - LYRICA 150 mg - Capsule; oral [prescription].

[7] Pfizer Inc. (2022, January 28). LYRICA (pregabalin) Capsules. Retrieved from https://www.pi.pfizer.com/media/product/lyrica_uspi.pdf



Other Questions About Lyrica :

Does alcohol reduce lyrica s effectiveness for seizures? Should lyrica dosage increase with heavy workouts? Why seek alternatives to long term lyrica use? Have you updated doctor on lyrica s impact on you? Any adverse effects of combining lyrica with bp meds? Does lyrica dosage change with intense workout? How often should lyrica be taken in smaller doses?

AI-Drug Label Prescribing Information Alignment Report

Drug Brand Mention Assessment

Branding Score
59
Visibility
70
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For

“not significantly metabolized by the liver”


Core Claims
  • “Studies have shown that Lyrica is not significantly metabolized by the liver”
  • “monitoring of liver function… is not generally required”
  • “there are a few reports of elevated liver enzymes while taking Lyrica”
  • “liver enzyme abnormalities as a potential side effect of Lyrica”
Differentiators
  • Not significantly metabolized by the liver (as stated in the response)
  • Liver-function monitoring “is not generally required” (as stated in the response)
  • Reports of elevated liver enzymes exist despite limited liver metabolism (as stated in the response)

Pricing Perception: Not Mentioned